Cargando…
Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial
BACKGROUND AND OBJECTIVE: Vertigo derived from peripheral vestibular disorders is quite frequently encountered in daily clinical practice and can be a severely disabling symptom associated with substantial impairment of health-related quality of life for the affected patients. Betahistine, a structu...
Autores principales: | Scholtz, Arne W., Hahn, Ales, Stefflova, Bohdana, Medzhidieva, Daniela, Ryazantsev, Sergey V., Paschinin, Alexander, Kunelskaya, Natalia, Schumacher, Kai, Weisshaar, Gerhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800407/ https://www.ncbi.nlm.nih.gov/pubmed/31571128 http://dx.doi.org/10.1007/s40261-019-00858-6 |
Ejemplares similares
-
Cinnarizine and dimenhydrinate in the treatment of vertigo in medical practice
por: Scholtz, Arne-Wulf, et al.
Publicado: (2015) -
Efficacy and Safety of a Fixed-Dose Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg in the Treatment of Patients with Vestibular Vertigo: An Individual Patient Data Meta-Analysis of Randomised, Double-Blind, Controlled Clinical Trials
por: Scholtz, Arne W., et al.
Publicado: (2022) -
Cinnarizine/dimenhydrinate for vertigo
Publicado: (2021) -
Efficacy and Pharmacological Appropriateness of Cinnarizine and Dimenhydrinate in the Treatment of Vertigo and Related Symptoms
por: Plescia, Fulvio, et al.
Publicado: (2021) -
Effectiveness of betahistine (48 mg/day) in patients with vestibular vertigo during routine practice: The VIRTUOSO study
por: Parfenov, Vladimir A., et al.
Publicado: (2017)